SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (483)6/18/2004 3:21:23 PM
From: fred hayes   of 496
 
Tuck: Some hints of what GLFD has in mind.

11/06/04 PR. Per study investigator, "***ideal profile for use in providing mild to moderate sedation in patients undergoing elective procedures such as colonoscopy. ***desired level of sedation was more rapidly achieved and was optimal for the duration of the procedure. ***unlike patients treated with midazolam or other medications typically used in this setting, patients receiving Aquavan Injection leave the endoscopy suite clear-headed ***"

***second Phase II clinical study was to evaluate *** compared to Disoprivan *** for use in pre-operative sedation, anesthesia induction and maintenance, and post-operative ICU sedation in patients undergoing coronary artery bypass surgery."
***
"Aquavan Injection compared vary favorable to Disoprivan***.

2/26/03 conf call. My notes show $250 million market potential with $80-120 million expected revenue potential for A. But this must have been for certain indications only, as an annual report showed a chart that indicated market potential for A at over $500 million. Confusing, and maybe not that helpful to you...

Anyway, sold my small position awhile back. Who knows...maybe the best indication of A's potential is the open market purchase of GLFD by insiders who spent $550 thousand in December 03 (at about $6 per share). Now that's something I understand.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext